31(top 2%)
papers
1.3K(top 2%)
citations
14(top 2%)
h-index
24(top 2%)
g-index
33
all documents
1.4K
doc citations
471
citing journals

Top Articles

#TitleJournalYearCitations
1EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritisAnnals of the Rheumatic Diseases2013504
2The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness studyHealth Technology Assessment2016313
3Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide CohortAmerican Journal of Respiratory and Critical Care Medicine2019146
4The Epidemiology of Low- and High-Energy Distal Radius Fracture in Middle-Aged and Elderly Men and Women in Southern NorwayPLoS ONE201275
5Short- and long-term mortality in males and females with fragility hip fracture in Norway. A population-based studyClinical Interventions in Aging201350
6Cardiovascular disease risk profiles in inflammatory joint disease entitiesArthritis Research and Therapy201740
7Incidence rates of fragility hip fracture in middle-aged and elderly men and women in southern NorwayAge and Ageing201238
8Long-term outcome in juvenile-onset mixed connective tissue disease: a nationwide Norwegian studyAnnals of the Rheumatic Diseases201734
9Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohortRheumatology202028
10Mortality after Distal Radius Fracture in Men and Women Aged 50 Years and Older in Southern NorwayPLoS ONE201424
11Guideline recommended treatment to targets of cardiovascular risk is inadequate in patients with inflammatory joint diseasesInternational Journal of Cardiology201921
12Interleukin 1β Blockade Improves Signs and Symptoms of Chronic Calcium Pyrophosphate Crystal Arthritis Resistant to TreatmentJournal of Clinical Rheumatology201219
13Leflunomide versus methotrexate in treatment of giant cell arteritis: comparison of efficacy, safety, and drug survivalScandinavian Journal of Rheumatology201916
14Short term in-patient rehabilitation in axial spondyloarthritis - the results of a 2-week program performed in daily clinical practiceBMC Research Notes201315
15Risk factors for osteoporosis and factors related to the use of DXA in NorwayArchives of Osteoporosis201514
16Diagnosing giant cell arteritis: a comprehensive practical guide for the practicing rheumatologistRheumatology202112
17Is it safe to use TNF-α blockers for systemic inflammatory disease in patients with heart failure? Importance of dosage and receptor specificityInternational Journal of Cardiology201310
18Feasibility of cardiovascular disease risk assessments in rheumatology outpatient clinics: experiences from the nationwide NOCAR projectRMD Open20189
19Increased Incidence of Giant Cell Arteritis in Urban Areas?Journal of Rheumatology20195
20Discrepancies in risk age and relative risk estimations of cardiovascular disease in patients with inflammatory joint diseasesInternational Journal of Cardiology20183
21Severe deterioration of newly diagnosed Takayasu arteritis in a patient re-treated with interferon beta-1α for concomitant longstanding multiple sclerosisModern Rheumatology20121
22POS1451 DEVELOPING A TOOL TO MEASURE THE LEARNING CURVE: ENTHESITIS ULTRASOUND IN PSORIASIS ARTHRITISAnnals of the Rheumatic Diseases20211
23AB0785 TREATING IDIOPATHIC RECURRENT PERICARDITIS WITH INTERLEUKIN-1 INHIBITORS - A SINGLE CENTER EXPERIENCEAnnals of the Rheumatic Diseases20211
24Severe deterioration of newly diagnosed Takayasu arteritis in a patient re-treated with interferon beta-1α for concomitant longstanding multiple sclerosisModern Rheumatology20121
25FRI0219 Involvement of supra-aortic vessels in giant cell arteritis diagnosed by color duplex ultrasonographyAnnals of the Rheumatic Diseases20130
26SAT0385 Lack of Correlation between Clinical and Ultrasonographic Evidence of Disease Activity in Psoriatic Arthritis:Annals of the Rheumatic Diseases20140
27AB0807 Cardiovascular Risk Factors and Cardiovascular Disease in Psoriatic ArthritisAnnals of the Rheumatic Diseases20150
28AB0381 VALIDATING DRAFT DCVAS CRITERIA IN A SINGLE CENTER GCA COHORT IN SOUTHERN NORWAYAnnals of the Rheumatic Diseases20210
29SAT0534 Annual incidence of giant cell arteritis in urban and rural areas in western norway 1972–201220180
30Comment on: Diagnosing giant cell arteritis: a comprehensive practical guide for the practicing rheumatologist: replyRheumatology20220
31POS0880 CHARACTERISTICS AND DISEASE COURSE OF UNTREATED PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSISAnnals of the Rheumatic Diseases20220
32POS0387 RISK STRATIFICATION APPROACHES PERFORM DIFFERENTLY IN SSc-ASSOCIATED PAH IN EUSTARAnnals of the Rheumatic Diseases20220
33Risk stratification approaches perform differently in SSc-associated PAH in EUSTAR20220